A detailed history of Bamco Inc transactions in Glaukos Corp stock. As of the latest transaction made, Bamco Inc holds 20,000 shares of GKOS stock, worth $2.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$2.77 Million
Previous $2.37 Million 10.05%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $1.79 Million - $2.37 Million
20,000 New
20,000 $2.37 Million
Q4 2017

Feb 14, 2018

SELL
$24.5 - $36.01 $53.8 Million - $79 Million
-2,194,059 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$31.26 - $42.03 $68.6 Million - $92.2 Million
2,194,059
2,194,059 $72.4 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.59B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.